ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial

7 months ago 4

ARTICLE AD BOX

Amylyx Pharmaceuticals has announced it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S. following its failure in a late-stage clinical trial.

1. Homepage
2. World News
3. ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial